Babette Aicher

732 total citations
28 papers, 607 citations indexed

About

Babette Aicher is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Babette Aicher has authored 28 papers receiving a total of 607 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 7 papers in Organic Chemistry and 6 papers in Oncology. Recurrent topics in Babette Aicher's work include Cancer therapeutics and mechanisms (5 papers), Bioactive Compounds and Antitumor Agents (4 papers) and Click Chemistry and Applications (3 papers). Babette Aicher is often cited by papers focused on Cancer therapeutics and mechanisms (5 papers), Bioactive Compounds and Antitumor Agents (4 papers) and Click Chemistry and Applications (3 papers). Babette Aicher collaborates with scholars based in Germany, Austria and France. Babette Aicher's co-authors include Thomas Müller, Axel Ullrich, Markus M. Lerch, Manfred Schmolz, E Günther, M.C. Wahl, Michael Teifel, Stefan Jäkel, Herbert Jäckle and Ralf Jauch and has published in prestigious journals such as The Journal of Cell Biology, The EMBO Journal and Cancer Research.

In The Last Decade

Babette Aicher

28 papers receiving 592 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Babette Aicher Germany 11 423 140 105 79 52 28 607
Jacint Boix Spain 14 383 0.9× 94 0.7× 128 1.2× 50 0.6× 51 1.0× 22 563
Atul D. Jain United States 11 516 1.2× 115 0.8× 131 1.2× 69 0.9× 82 1.6× 17 711
Thomas Fuchß Germany 13 417 1.0× 114 0.8× 175 1.7× 45 0.6× 53 1.0× 29 614
Alexandre Patenaude Canada 14 395 0.9× 110 0.8× 94 0.9× 93 1.2× 81 1.6× 23 661
Nuria Ajenjo Spain 9 423 1.0× 80 0.6× 136 1.3× 44 0.6× 81 1.6× 12 598
Alexios-Leandros Skaltsounis Greece 3 523 1.2× 149 1.1× 65 0.6× 38 0.5× 23 0.4× 4 708
Long G. Wang United States 10 465 1.1× 113 0.8× 244 2.3× 40 0.5× 73 1.4× 11 761
Xiaolu Zhang China 14 303 0.7× 219 1.6× 135 1.3× 81 1.0× 169 3.3× 43 774
Lucy H. Elliott United Kingdom 10 490 1.2× 113 0.8× 125 1.2× 89 1.1× 127 2.4× 12 782
Darcy Bates United States 12 391 0.9× 91 0.7× 185 1.8× 71 0.9× 58 1.1× 17 704

Countries citing papers authored by Babette Aicher

Since Specialization
Citations

This map shows the geographic impact of Babette Aicher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Babette Aicher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Babette Aicher more than expected).

Fields of papers citing papers by Babette Aicher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Babette Aicher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Babette Aicher. The network helps show where Babette Aicher may publish in the future.

Co-authorship network of co-authors of Babette Aicher

This figure shows the co-authorship network connecting the top 25 collaborators of Babette Aicher. A scholar is included among the top collaborators of Babette Aicher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Babette Aicher. Babette Aicher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Massihnia, Daniela, Amir Avan, Niccola Funel, et al.. (2017). Phospho-Akt overexpression is prognostic and can be used to tailor the synergistic interaction of Akt inhibitors with gemcitabine in pancreatic cancer. Journal of Hematology & Oncology. 10(1). 9–9. 69 indexed citations
2.
3.
Blayo, Anne‐Laure, Séverine Denoyelle, Céline M’Kadmi, et al.. (2016). New ligands of the ghrelin receptor based on the 1,2,4-triazole scaffold by introduction of a second chiral center. Bioorganic & Medicinal Chemistry Letters. 26(10). 2408–2412. 6 indexed citations
4.
Blayo, Anne‐Laure, Babette Aicher, Céline M’Kadmi, et al.. (2014). New trisubstituted 1,2,4-triazoles as ghrelin receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 25(1). 20–24. 7 indexed citations
5.
Logé, Cédric, Marc Le Borgne, Babette Aicher, et al.. (2014). Discovery of (7-aryl-1,5-naphthyridin-2-yl)ureas as dual inhibitors of ERK2 and Aurora B kinases with antiproliferative activity against cancer cells. Bioorganic & Medicinal Chemistry Letters. 24(16). 3748–3752. 8 indexed citations
6.
Fensterle, Joachim, et al.. (2014). Current View on the Mechanism of Action of Perifosine in Cancer. Anti-Cancer Agents in Medicinal Chemistry. 14(4). 629–635. 33 indexed citations
7.
Schirmer, Eva, Wolfgang Hölzer, Helmut Spreitzer, et al.. (2013). Synthesis and biological evaluation of new cytotoxic indazolo[4,3-gh]isoquinolinone derivatives. Bioorganic & Medicinal Chemistry Letters. 23(6). 1846–1852. 4 indexed citations
8.
Borgne, Marc Le, Babette Aicher, Michael Teifel, et al.. (2013). Discovery of 7‐Aryl‐Substituted (1,5‐Naphthyridin‐4‐yl)ureas as Aurora Kinase Inhibitors. ChemMedChem. 9(1). 217–232. 10 indexed citations
9.
Schirmer, Eva, et al.. (2013). Synthesis and antiproliferative activity of new cytotoxic tri- and tetraazabenzo[3,2-a]fluorene-5,6-dione derivatives. Bioorganic & Medicinal Chemistry Letters. 23(19). 5264–5266. 4 indexed citations
10.
Aicher, Babette, et al.. (2012). Abstract 2877: Perifosine alone and in combination with antimetabolites interferes with NF-kB pathway activation in colon cancer cell lines. Cancer Research. 72(8_Supplement). 2877–2877. 1 indexed citations
11.
Schirmer, Eva, Wolfgang Hölzer, Helmut Spreitzer, et al.. (2011). Synthesis and antiproliferative activity of new cytotoxic azanaphthoquinone pyrrolo-annelated derivatives: Part II. Bioorganic & Medicinal Chemistry Letters. 21(10). 3117–3121. 6 indexed citations
12.
Schmidt‐Hieber, Martin, Babette Aicher, Philipp Lohneis, et al.. (2011). In vitro effects of perifosine, bortezomib and lenalidomide against hematopoietic progenitor cells from healthy donors. Investigational New Drugs. 30(4). 1396–1403. 3 indexed citations
13.
Schmidt‐Hieber, Martin, Andreas Weimann, Babette Aicher, et al.. (2010). In vitro cytotoxicity of the novel antimyeloma agents perifosine, bortezomib and lenalidomide against different cell lines. Investigational New Drugs. 30(2). 480–489. 9 indexed citations
14.
Schirmer, Eva, Wolfgang Hölzer, Helmut Spreitzer, et al.. (2010). Synthesis and biological evaluation of new cytotoxic azanaphthoquinone pyrrolo-annelated derivatives. Bioorganic & Medicinal Chemistry Letters. 20(13). 3950–3952. 11 indexed citations
15.
16.
17.
Hölzer, Wolfgang, et al.. (2007). Synthesis and biological evaluation of novel cytotoxic azanaphthoquinone annelated pyrrolo oximes. Bioorganic & Medicinal Chemistry Letters. 17(22). 6091–6095. 19 indexed citations
18.
Jauch, Ralf, Min‐Kyu Cho, Stefan Jäkel, et al.. (2006). Mitogen‐activated protein kinases interacting kinases are autoinhibited by a reprogrammed activation segment. The EMBO Journal. 25(17). 4020–4032. 55 indexed citations
19.
Jauch, Ralf, et al.. (2005). Crystal Structures of the Mnk2 Kinase Domain Reveal an Inhibitory Conformation and a Zinc Binding Site. Structure. 13(10). 1559–1568. 51 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jacint Boix Breakdown of academic impact, for papers by Atul D. Jain Breakdown of academic impact, for papers by Thomas Fuchß Breakdown of academic impact, for papers by Alexandre Patenaude Breakdown of academic impact, for papers by Nuria Ajenjo Breakdown of academic impact, for papers by Alexios-Leandros Skaltsounis Breakdown of academic impact, for papers by Long G. Wang Breakdown of academic impact, for papers by Xiaolu Zhang Breakdown of academic impact, for papers by Lucy H. Elliott Breakdown of academic impact, for papers by Darcy Bates
Rankless by CCL
2026